{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:39:11Z","timestamp":1762875551601},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T00:00:00Z","timestamp":1377302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00380-013-0399-x","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T06:25:03Z","timestamp":1377239103000},"page":"578-583","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation"],"prefix":"10.1007","volume":"29","author":[{"given":"Soon Yong","family":"Suh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woong Chol","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pyung Chun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Il","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyounghoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hwan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taehoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Suck","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eak Kyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,24]]},"reference":[{"key":"399_CR1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370\u20132375","journal-title":"JAMA"},{"key":"399_CR2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11886-006-0070-6","volume":"8","author":"A Hersi","year":"2006","unstructured":"Hersi A, Wyse DG (2006) Medical management of atrial fibrillation. Curr Cardiol Rep 8:323\u2013329","journal-title":"Curr Cardiol Rep"},{"key":"399_CR3","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"S Connolly","year":"2006","unstructured":"ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367:1903\u20131912","journal-title":"Lancet"},{"key":"399_CR4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCINTERVENTIONS.111.965186","volume":"4","author":"DP Faxon","year":"2011","unstructured":"Faxon DP, Eikelboom JW, Berger PB, Holmes DR Jr, Bhatt DL, Moliterno DJ, Becker RC, Angiolillo DJ (2011) Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary. Circ Cardiovasc Interv 4:522\u2013534","journal-title":"Circ Cardiovasc Interv"},{"key":"399_CR5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000089548","volume":"105","author":"Y Konstantino","year":"2006","unstructured":"Konstantino Y, Iakobishvili Z, Porter A, Sandach A, Zahger D, Hod H, Hammerman H, Gottlieb S, Behar S, Hasdai D (2006) Aspirin, warfarin and a thienopyridine for acute coronary syndromes. Cardiology 105:80\u201385","journal-title":"Cardiology"},{"key":"399_CR6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.08-0350","volume":"134","author":"S Manzano-Fern\u00e1ndez","year":"2008","unstructured":"Manzano-Fern\u00e1ndez S, Pastor FJ, Mar\u00edn F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Vald\u00e9s M, Lip GY (2008) Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest 134:559\u2013567","journal-title":"Chest"},{"key":"399_CR7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.amjcard.2012.01.353","volume":"109","author":"A Rubboli","year":"2012","unstructured":"Rubboli A, Magnavacchi P, Guastaroba P, Saia F, Vignali L, Giacometti P, Franco N, Benassi A, Varani E, Campo G, Manari A, De Palma R, Marzocchi A (2012) Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry). Am J Cardiol 109:1411\u20131417","journal-title":"Am J Cardiol"},{"key":"399_CR8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00380-011-0185-6","volume":"27","author":"G Kozda\u011f","year":"2012","unstructured":"Kozda\u011f G, Yaymac\u0131 M, Erta\u015f G, Celikyurt U, Sahin T, K\u0131l\u0131\u00e7 T, Ural D (2012) Aspirin, clopidogrel, and warfarin use and outcomes in a cohort of 580 patients discharged after hospitalization for decompensated heart failure. Heart Vessels 27:568\u2013575","journal-title":"Heart Vessels"},{"key":"399_CR9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1253\/circj.CJ-09-0880","volume":"74","author":"F Gao","year":"2010","unstructured":"Gao F, Zhou YJ, Wang ZJ, Shen H, Liu XL, Nie B, Yan ZX, Yang SW, de Jia A, Yu M (2010) Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation. Circ J 74:701\u2013708","journal-title":"Circ J"},{"key":"399_CR10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4070\/kcj.2011.41.10.578","volume":"41","author":"SW Jang","year":"2011","unstructured":"Jang SW, Rho TH, Kim DB, Cho EJ, Kwon BJ, Park HJ, Shin WS, Kim JH, Lee JM, Moon KW, Oh YS, Yoo KD, Youn HJ, Lee MY, Chung WS, Seung KB, Kim JH (2011) Optimal antithrombotic strategy in patients with atrial fibrillation after coronary stent implantation. Korean Circ J 41:578\u2013582","journal-title":"Korean Circ J"},{"key":"399_CR11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","volume":"51","author":"JM Ruiz-Nodar","year":"2008","unstructured":"Ruiz-Nodar JM, Mar\u00edn F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Vald\u00e9s M, Lip GY (2008) Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol 51:818\u2013825","journal-title":"J Am Coll Cardiol"},{"key":"399_CR12","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369\u20132429","journal-title":"Eur Heart J"},{"key":"399_CR13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1378\/chest.130.6.1823","volume":"130","author":"GY Lip","year":"2006","unstructured":"Lip GY, Karpha M (2006) Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. Chest 130:1823\u20131827","journal-title":"Chest"},{"key":"399_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","volume":"50","author":"AY Shen","year":"2007","unstructured":"Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W (2007) Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 50:309\u2013315","journal-title":"J Am Coll Cardiol"},{"key":"399_CR15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1253\/circj.71.761","volume":"71","author":"S Suzuki","year":"2007","unstructured":"Suzuki S, Yamashita T, Kato T, Fujino T, Sagara K, Sawada H, Aizawa T, Fu LT (2007) Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation. Circ J 71:761\u2013765","journal-title":"Circ J"},{"key":"399_CR16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1160\/TH09-08-0563","volume":"102","author":"S Apostolakis","year":"2009","unstructured":"Apostolakis S, Shantsila E, Lip GY, Lane DA (2009) Contra: Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation. Thromb Haemost 102:914\u2013915","journal-title":"Thromb Haemost"},{"key":"399_CR17","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.amjcard.2008.08.021","volume":"102","author":"R Rossini","year":"2008","unstructured":"Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ (2008) Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Am J Cardiol 102:1618\u20131623","journal-title":"Am J Cardiol"},{"key":"399_CR18","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/eurheartj\/ehm186","volume":"28","author":"MC Nguyen","year":"2007","unstructured":"Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, Budaj A, Gulba DC, Allegrone J, Brieger D, GRACE Investigators (2007) Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 28:1717\u20131722","journal-title":"Eur Heart J"},{"key":"399_CR19","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","volume":"48","author":"M Pfisterer","year":"2006","unstructured":"Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C, BASKET-LATE Investigators (2006) Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48:2584\u20132591","journal-title":"J Am Coll Cardiol"},{"key":"399_CR20","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.jacc.2008.01.063","volume":"51","author":"SS Brar","year":"2008","unstructured":"Brar SS, Kim J, Brar SK, Zadegan R, Ree M, Liu IL, Mansukhani P, Aharonian V, Hyett R, Shen AY (2008) Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. J Am Coll Cardiol 51:2220\u20132227","journal-title":"J Am Coll Cardiol"},{"key":"399_CR21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","volume":"297","author":"EL Eisenstein","year":"2007","unstructured":"Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM (2007) Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297:159\u2013168","journal-title":"JAMA"},{"key":"399_CR22","author":"K Ohkubo","year":"2013","unstructured":"Ohkubo K, Fujimoto Y, Iwata Y, Kitahara H, Kadohira T, Sugimoto K, Morino T, Kobayashi Y (2013) Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial. Heart Vessels. doi: 10.1007\/S00380-012-0318-6","journal-title":"Heart Vessels"},{"key":"399_CR23","doi-asserted-by":"crossref","unstructured":"Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman JP, Adriaenssens T, Vrolix M, Heestermans AA, Vis MM, Tijsen JG, van \u2019t Hof AW, ten Berg JM; (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. doi: 10.1016\/S0140-6736(12)62177-1","DOI":"10.1016\/S0140-6736(12)62177-1"},{"key":"399_CR24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4244\/EIJV5I2A43","volume":"5","author":"D Zahger","year":"2009","unstructured":"Zahger D, Ilia R (2009) Coronary stenting in warfarin treated patients. EuroIntervention 5:277\u2013281","journal-title":"EuroIntervention"},{"key":"399_CR25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jacc.2009.03.044","volume":"54","author":"DR Holmes Jr","year":"2009","unstructured":"Holmes DR Jr, Kereiakes DJ, Kleiman NS, Moliterno DJ, Patti G, Grines CL (2009) Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol 54:95\u2013109","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-013-0399-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-013-0399-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-013-0399-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T19:31:25Z","timestamp":1563737485000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-013-0399-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,24]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1007\/s00380-013-0399-x","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,24]]}}}